SILVER
Waters Corporation
Cell and gene therapies are the new frontier in medicine. Advancing their development, ensuring their safety and efficacy, and bringing their costs down requires new analytical tools and techniques.
Waters scientists and engineers are deeply committed to supporting the analytical needs of cell and gene therapy developers through our existing tools and an ongoing release of innovative new solutions designed to serve your unmet needs and deliver enhanced analytical performance and productivity.
From the genetic material contained in cell and gene therapies (synthetic oligonucleotides, mRNA, other long-chain nucleic acids) to the delivery vehicles required to safely transmit this material into targeted cells, (viral vectors, lipid nanoparticles (LNPs) and virus-like particles (VLPs)), you can accelerate the characterization of these large, multi-component drug formulations at both the component level and as fully assembled drug product to ensure their safety and efficacy.
Don’t miss our Posters!
Innovations in Size Exclusion HPLC for Efficient Analyses and Insights on AAV Manufacturing
Ref. P0221 – Presented during Poster Session I on Tuesday 22 October from 19:30 to 21:00
Novel 'ultra-short' liquid chromatography columns for efficient high-throughput oligonucleotide analysis
Ref. P0833 – Presented during Poster Session III on Thursday 24 October from 14:00 to 15:30
